Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Lepore Patrick G
Relationship:   Director
City:   Fair Lawn
State:   NJ
   
Insider Summary:
  
   
Companies Owned :   6    
Direct Shares   1,081,895    

Indirect Shares

   0      
Direct Value   $1,374,296    

Indirect Value

   $0      
Total Shares   1,081,895      
Total Value   $1,374,296      


Innoviva Inc $919,627 Lannett Co Inc $380,118 Matinas Biopharma Holdings, Inc. $66,400 VYNE Therapeutics Inc $8,151 Innoviva Inc $919,627 Lannett Co Inc $380,118 Matinas Biopharma Holdings, Inc. $66,400 VYNE Therapeutics Inc $8,151
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    10   
    0    

     Stock price went up :
    3   
    0    
     Stock price went down :
    7   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
   -39.4%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Par Pharmaceutical Companies Inc PRX Executive Chairman, Di... 2012-09-28 0 2012-09-28 0    Premium*  
            PharMerica Corporation PMC Director 2017-12-07 0 2013-01-14 0    Premium*  
            Innoviva Inc INVA Director 2017-04-20 58,278 2016-10-26 0    Premium*  
            Lannett Co Inc LCI Director 2022-11-10 587,145 2018-05-11 0    Premium*  
            Matinas Biopharma Holdings, Inc. MTNB Director 2020-05-14 400,000 2019-05-16 0    Premium*  
            VYNE Therapeutics Inc VYNE Director 2023-11-15 36,472 2020-12-03 0    Premium*  
* Premium Members only  

Records found :    25         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 1
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
PRX Par Pharmaceutical Compan... Executive Chairman   •       •      –    2012-09-28 4 D $50.00 $1,900,000 I/I (38,000) 0 0 -
PRX Par Pharmaceutical Compan... Executive Chairman   •       •      –    2012-09-28 4 D $50.00 $9,589,600 D/D (191,792) 0 0 -
PRX Par Pharmaceutical Compan... Chairman, Pres and CEO   •       •      –    2011-01-04 4 D $39.79 $116,983 D/D (2,940) 220,553 0 -
PRX Par Pharmaceutical Compan... Chairman, Pres, CEO   •       –      –    2011-01-10 4/A D $36.00 $251,352 D/D (6,982) 265,817 0 -
PRX Par Pharmaceutical Compan... Chairman, President & CEO   •       •      –    2011-01-10 4 D $36.00 $193,140 D/D (5,365) 264,062 0 -
PRX Par Pharmaceutical Compan... Chairman, Pres and CEO   •       •      –    2011-01-11 4 D $35.98 $964,120 D/D (26,796) 264,270 0 -
PRX Par Pharmaceutical Compan... Chairman and CEO   •       •      –    2012-01-11 4 D $35.65 $58,894 D/D (1,652) 191,793 0 -
PRX Par Pharmaceutical Compan... Chairman and CEO   •       •      –    2012-01-09 4 D $35.09 $188,258 D/D (5,365) 193,445 0 -
PRX Par Pharmaceutical Compan... Chairman, President & CEO   •       •      –    2011-05-09 4 S $34.00 $2,236,969 D/D (65,467) 263,570 0 -
PRX Par Pharmaceutical Compan... Chairman, Pres & CEO   •       •      –    2010-11-01 4 D $32.93 $96,386 D/D (2,927) 223,493 0 -
PMC PharMerica Corporation Director   –       •      –    2017-12-07 4 D $29.25 $864,923 D/D (29,570) 0 0 -
PRX Par Pharmaceutical Compan... Chairman, President & CEO   •       •      –    2011-08-09 4 D $29.09 $252,792 D/D (8,690) 254,880 0 -
PRX Par Pharmaceutical Compan... Chairman, President and CEO   •       •      –    2011-03-22 4 D $29.00 $71,195 D/D (2,455) 263,570 0 -
PRX Par Pharmaceutical Compan... Chairman, CEO and President   •       •      –    2010-08-09 4 D $28.51 $190,732 D/D (6,690) 226,420 0 -
PRX Par Pharmaceutical Compan... Chairman, President & CEO   •       •      –    2011-09-06 4 B $25.92 $207,360 I/I 8,000 23,000 2.66 -
PRX Par Pharmaceutical Compan... Chairman, Pres, CEO   •       •      –    2010-01-08 4 D $25.88 $106,884 D/D (4,130) 236,272 0 -
PRX Par Pharmaceutical Compan... Chairman, Pres, CEO   •       •      –    2010-01-11 4 D $25.80 $32,818 D/D (1,272) 235,000 0 -
PRX Par Pharmaceutical Compan... Chairman, President and CEO   •       •      –    2010-03-22 4 D $25.09 $47,420 D/D (1,890) 233,110 0 -
PRX Par Pharmaceutical Compan... Chairman, President and CEO   •       •      –    2009-10-30 4 D $20.97 $61,379 D/D (2,927) 213,336 0 -
PRX Par Pharmaceutical Compan... Chairman, President & CEO   •       •      –    2008-03-24 4 A $18.37 $34,719 D/D 1,890 180,720 0 -
PRX Par Pharmaceutical Compan... Chairman, CEO and President   •       •      –    2007-10-03 4 B $18.36 $550,800 I/I 30,000 15,000 2.66 -
PRX Par Pharmaceutical Compan... Chairman, President & CEO   •       •      –    2009-08-10 4 D $15.95 $106,706 D/D (6,690) 216,263 0 -
PRX Par Pharmaceutical Compan... Chairman and CEO   •       •      –    2008-08-11 4 D $15.23 $101,889 D/D (6,690) 174,030 0 -
LCI Lannett Co Inc Director   –       •      –    2018-05-11 4 B $15.13 $378,250 D/D 25,000 26,700 2.39 -
PRX Par Pharmaceutical Compan... Chairman, President & CEO   •       •      –    2011-05-09 4 OE $13.06 $854,999 D/D 65,467 329,037 0 -
  25  Records found
  1     
  Page 1 of 1  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us